​

AVITA Medical (RCEL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RCEL Stock Forecast

AVITA Medical (RCEL) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $4.00, with a high of $4.00 and a low of $4.00. This represents a 9.29% increase from the last price of $3.66.

- $4 $8 $12 $16 $20 High: $4 Avg: $4 Low: $4 Last Closed Price: $3.66

RCEL Stock Rating

AVITA Medical stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (57.14%), 3 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 3 4 Strong Sell Sell Hold Buy Strong Buy

RCEL Price Target Upside V Benchmarks

TypeNameUpside
StockAVITA Medical9.29%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks20.18%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$4.00$4.00$9.00
Last Closing Price$3.66$3.66$3.66
Upside/Downside9.29%9.29%145.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-4-1-5
Sep, 25-4-1-5
Aug, 25-31--4
Jul, 25-31--4
Jun, 25-41--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 17, 2025Frank TakkinenLake Street$4.00$5.38-25.65%9.29%
Jan 08, 2025Brooks O'NeilLake Street$14.00$14.06-0.43%282.51%
May 14, 2024Matt O'BrienPiper Sandler$9.00$8.357.78%145.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 17, 2025Lake StreetBuyHolddowngrade
Aug 08, 2025BTIGBuySelldowngrade
Jan 08, 2025Lake StreetBuyBuyhold
Dec 24, 2024Cantor FitzgeraldOverweightOverweighthold
Aug 09, 2024Cowen & Co.BuyBuyhold
May 14, 2024Bank of America SecuritiesBuyBuyhold
May 14, 2024Piper SandlerNeutraldowngrade
Jun 27, 2023Cantor FitzgeraldOverweightinitialise
Jun 16, 2021BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $0 $5 $10 $15 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--$-1.57------
Avg Forecast$-0.92$-2.77$-1.63$-2.48$-3.56$-1.12$1.43$9.11$16.90
High Forecast$-0.87$-2.63$-1.57$-2.41$-3.20$-0.91$8.20$9.76$18.11
Low Forecast$-0.96$-2.89$-1.80$-2.63$-3.77$-1.54$-0.97$8.72$16.17
Surprise %---3.68%------

Revenue Forecast

$0 $140M $280M $420M $560M $700M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--$50.56M------
Avg Forecast$16.58M$25.34M$34.18M$50.14M$66.51M$103.68M$158.35M$368.30M$627.30M
High Forecast$17.11M$26.15M$36.94M$52.89M$70.16M$109.36M$162.11M$388.50M$661.70M
Low Forecast$15.91M$24.32M$33.08M$48.47M$64.30M$100.23M$154.59M$356.05M$606.43M
Surprise %--47.91%------

Net Income Forecast

$-100M $20M $140M $260M $380M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--$-39.17M------
Avg Forecast$-23.00M$-69.33M$-47.03M$-35.38M$-87.06M$-30.66M$28.81M$230.96M$422.60M
High Forecast$-21.80M$-65.72M$-37.62M$-28.30M$-79.99M$-22.81M$205.06M$244.01M$452.72M
Low Forecast$-23.95M$-72.20M$-56.44M$-42.46M$-94.13M$-38.52M$-24.24M$217.92M$404.32M
Surprise %---16.72%------

RCEL Forecast FAQ

Is AVITA Medical stock a buy?

AVITA Medical stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AVITA Medical is a favorable investment for most analysts.

What is AVITA Medical's price target?

AVITA Medical's price target, set by 7 Wall Street analysts, averages $4 over the next 12 months. The price target range spans from $4 at the low end to $4 at the high end, suggesting a potential 9.29% change from the previous closing price of $3.66.

How does AVITA Medical stock forecast compare to its benchmarks?

AVITA Medical's stock forecast shows a 9.29% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (20.18%).

What is the breakdown of analyst ratings for AVITA Medical over the past three months?

  • October 2025: 0% Strong Buy, 80.00% Buy, 0% Hold, 20.00% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 80.00% Buy, 0% Hold, 20.00% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is AVITA Medical’s EPS forecast?

AVITA Medical's average annual EPS forecast for its fiscal year ending in December 2023 is $-2.48, marking a 57.96% increase from the reported $-1.57 in 2022. Estimates for the following years are $-3.56 in 2024, $-1.12 in 2025, $1.43 in 2026, $9.11 in 2027, and $16.9 in 2028.

What is AVITA Medical’s revenue forecast?

AVITA Medical's average annual revenue forecast for its fiscal year ending in December 2023 is $50.14M, reflecting a -0.83% decrease from the reported $50.56M in 2022. The forecast for 2024 is $66.51M, followed by $103.68M for 2025, $158.35M for 2026, $368.3M for 2027, and $627.3M for 2028.

What is AVITA Medical’s net income forecast?

AVITA Medical's net income forecast for the fiscal year ending in December 2023 stands at $-35.381M, representing a -9.67% decrease from the reported $-39.168M in 2022. Projections indicate $-87.057M in 2024, $-30.663M in 2025, $28.81M in 2026, $230.96M in 2027, and $422.6M in 2028.